On Friday, the European Commission gave the green light to the marketing as a booster dose for people over 18 years of age of the COVID-19 vaccine from Sanofi and GSK, a serum approved following the positive opinion of the European Medicines Agency and which becomes the seventh vaccine allowed in the European Union.
It is a protein vaccine that the EMA and Brussels consider suitable to be administered as a booster dose to adult patients who have completed the first immunization regimen with another vaccine.
In September 2020, the European Union sealed a contract with Sanofi and GSK that gave an option to purchase up to 300 million doses of the vaccine from interested countries in the bloc once it received the approval of the health authorities. Member states can also use these vaccines to donate vaccines to low- and middle-income countries.
